David Niederseer
Overview
Explore the profile of David Niederseer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
1732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prognostic Value of Submaximal Cardiopulmonary Exercise Testing in Patients With Cardiac Amyloidosis
Willixhofer R, Ermolaev N, Kronberger C, Eslami M, Vilsmeier J, Rettl R, et al.
Circ Rep
. 2025 Feb;
7(2):76-85.
PMID: 39931706
Background: This study assessed the prognostic value of submaximal cardiopulmonary exercise testing (CPET) in cardiac amyloidosis and explored CPET as an alternative to the 6-min walk test (6MWT). Methods And...
2.
Wilczek F, van der Stouwe J, Petrasch G, Niederseer D
Sensors (Basel)
. 2025 Jan;
25(1.
PMID: 39796978
Continuous glucose monitoring (CGM) might provide immediate feedback regarding lifestyle choices such as diet and physical activity (PA). The impact of dietary habits and physical activity can be demonstrated in...
3.
Stiefel M, Brito da Silva H, Schmied C, Niederseer D
J Cardiovasc Dev Dis
. 2024 Dec;
11(12).
PMID: 39728269
Introduction: Balancing the well-documented benefits of regular exercise, particularly its positive impact on cardiovascular risk factors like hypertension, with the potential risks for patients with aortic aneurysms presents a significant...
4.
Shchendrygina A, Mewton N, Niederseer D, Kida K, Guidetti F, Jobbe Duval A, et al.
Am J Cardiol
. 2024 Oct;
236():42-48.
PMID: 39481586
Cardiac amyloidosis (CA) is still an underdiagnosed cause of heart failure (HF) and early disease recognition and timely disease-modifying therapy (DMT) administration translate to better outcomes. We aimed to assess...
5.
Stahli B, Schindler M, Schweiger V, Cammann V, Szawan K, Niederseer D, et al.
Eur J Clin Invest
. 2024 Oct;
54(12):e14317.
PMID: 39397275
Background: The clinical relevance of cardiac troponin (cTn) elevation in takotsubo syndrome (TTS) remains uncertain. The present study sought to investigate the role of cardiac troponin (cTn) elevations in mortality...
6.
Diagnostic and therapeutic practice for HFpEF across continents and regions: An international survey
Ingimarsdottir I, Vishram-Nielsen J, Einarsson H, Goldfeder S, Mewton N, Barasa A, et al.
ESC Heart Fail
. 2024 Oct;
12(1):487-496.
PMID: 39351634
Aims: This study aims to evaluate the worldwide variations in the diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF), using an HF survey distributed internationally to physicians,...
7.
van der Stouwe J, Godly K, Kraler S, Godly J, Matter C, Wenzl F, et al.
Eur J Clin Invest
. 2024 Oct;
54(12):e14314.
PMID: 39350322
Background: Inflammatory processes can trigger acute coronary syndromes (ACS) which may increase core body temperature (BT), a widely available low-cost marker of systemic inflammation. Herein, we aimed to delineate baseline...
8.
Schweiger V, Cammann V, Crisci G, Gilhofer T, Schlenker R, Niederseer D, et al.
J Am Coll Cardiol
. 2024 Sep;
84(13):1178-1189.
PMID: 39217551
Background: The perception of takotsubo syndrome (TTS) has evolved significantly over the years, primarily driven by increased recognition of acute complications and mortality. Objectives: This study aimed to explore temporal...
9.
Wang Y, Zeller M, Auffret V, Georgiopoulos G, Raber L, Roffi M, et al.
Eur Heart J
. 2024 Sep;
45(43):4564-4578.
PMID: 39217456
Background And Aims: Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. To test novel interventions, personalized...
10.
Wurzburger L, van der Stouwe J, Ghidoni C, Wiech P, Moser G, Petrasch G, et al.
J Clin Hypertens (Greenwich)
. 2024 Aug;
26(11):1209-1218.
PMID: 39190563
A hypertensive response to exercise is a precursor leading to hypertension, which is a major risk factor for the development of heart failure and diastolic dysfunction. Herein, we aimed to...